Navigation Links
Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S.
Date:9/4/2013

f the New Drug Application (NDA), after which time POZEN will transfer the NDA to Sanofi US.  The NDA was submitted in March 2013 and accepted for filing in May 2013 by the U.S. Food and Drug Administration (FDA). 

John R. Plachetka, Pharm.D., Chairman, President and Chief Executive Officer of POZEN Inc. said, "We are pleased to have Sanofi US commercialize PA8140 and PA32540 in the US.  We have been excited about the results of our Phase 3 clinical trials and look forward to the prospect of making this product available to cardiovascular patients at risk for gastric ulcers. Sanofi's dominant CV heritage and strong commitment to PA, make them the right partner for these products."

About PA  POZEN has created a portfolio of investigational integrated aspirin therapies - the PA product platform. The products in the PA portfolio are being developed with the goal of significantly reducing GI ulcers and other GI complications compared to taking enteric-coated or plain aspirin alone.

The first candidates are PA32540, containing 325 mg of aspirin, and PA8140, containing 81 mg of aspirin. Both products are a coordinated-delivery tablet combining immediate-release omeprazole (40 mg), a proton pump inhibitor, layered around a pH-sensitive coating of an aspirin core. This novel, patented product is intended for oral administration once a day and an indication is being sought for use for the secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers.

About Cardiovascular DiseasePatients with established coronary heart disease or cerebrovascular disease have a high risk of a subsequent cardiovascular event including myocardial infarction (MI), stroke and death from cardiovascular disease. For such patients, lifestyle changes and drug therapy are of proven benefit and may improve outcomes. Heart disease is the leading cause of death for both men and women in A
'/>"/>

SOURCE Sanofi US
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Pasteurs Fluzone High-Dose Vaccine Significantly More Effective Than Standard Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older
2. Sanofi Pasteur Announces Shipment of First Lots of 2013-2014 Seasonal Influenza Vaccine in U.S.
3. Sanofi US and Joslin Diabetes Center Announce Results from Multicultural Outreach Pilot at American Diabetes Association Scientific Sessions
4. Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
5. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
6. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
7. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
8. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
9. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
10. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
11. NextBio Announces Translational Medicine Partnership with Sanofi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 ... reveals it has helped seven million people across 13 ...   The GSF,s latest Progress Report ... helped seven million people in over 20,500 communities become ... seen eight million people gain access to hand-washing facilities. ...
(Date:6/2/2015)... MADRID , June 2, 2015 ... 10503) effectuée lors de la réunion annuelle de ... PharmaMar communique que Janssen Research & Development, LLC ... multicentrique de phase III SAR3007 qui démontrent une ... avec la trabectédine (YONDELIS ® ) comparé à ...
(Date:6/1/2015)... 2015 Lee Tran & Liang ... Snapchat and Yik Yak co-founder disputes, ... of the most promising biotechnology start-ups in the country, ... Jeffrey Sabados .  LTL represents Veronica Sara ... colleague and fellow scientist at the Massachusetts Institute of ...
Breaking Medicine Technology:Global Sanitation Fund Reports Major Sanitation & Hygiene Advances for Seven Million People in 13 Countries 2PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 2PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 3PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 4PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 5PharmaMar annonce que l'étude Janssen montre que la Trabectédine améliore la lutte contre la maladie chez les patients atteints du sarcome des tissus mous à un stade avancé 6Lee Tran & Liang LLP Files Co-Founder Lawsuit against Leading Biotech Start-up Resilience 2
... Alfacell Corporation,(Nasdaq: ACEL ) today announced ... at,the 5th Cancer Drug Research & Development conference ... ONCONASE stimulated,intracellular events as revealed by expression profiling ... show that ONCONASE conjugates,effectively kill human cancer cells ...
... the NYC Department of,Health "unveiled a brand new look for ... encourage New Yorker,s to ,get some.," The,Release said further that ... the campaign would include ads on TV and radio and,display ... 36 million,condoms were given out last year., Robert Peters, ...
Cached Medicine Technology:Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R) 2Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R) 3NYC Department of Health's 'Get Some NYC Condoms' Sends Wrong Message and Misuses Tax Dollars, says MIM President Bob Peters 2
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... Kathy Everette-Gaines as a 2015-2016 inductee into its ... recognized with this prestigious distinction for leadership in ... exclusively for professional women, boasting more than 700,000 ... “I’m pleased to welcome Kathy into this exceptional ...
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... Lenita F. Cornett, DSL, LSSBB (C), First Sergeant ... its VIP Woman of the Year Circle. She is ... military. NAPW is the nation's leading networking organization exclusively ... over 200 operating Local Chapters. , “I'm pleased to ...
(Date:6/1/2015)... June 01, 2015 Carson Energy also ... their investors IRA transactions. AdvantaIRA Trust, LLC is the ... the ability to fund positions using IRA’s does 2 ... on a project, even if there current cash position ... additional funding source for Carson and their investors to ...
(Date:6/1/2015)... York, New York (PRWEB) June 01, 2015 ... ( http://www.testosteronelawsuithub.com/ ) has amended the Case Management ... Inc.’s AndroGel testosterone gel. The Amended Order which ... of Illinois on May 29, 2015, directs the parties ... Court by August 10, 2015 that outlines parameters and ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Atagi Plastic ... have been named an Ultherapy® Ultra Treatment ... Surgery and Skin Aesthetics is one of only six ... a premier treatment provider. , Atagi Plastic Surgery ... the Denver area has led the practice to earn ...
Breaking Medicine News(10 mins):Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lenita F. Cornett, First Sergeant of the US Military, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4Health News:Atagi Plastic Surgery and Skin Aesthetics Named Ultherapy® Ultra Treatment Provider 2
... reduce the risk of asthma, according to Danish researchers. ... at the European Respiratory Society,s Annual Congress in Amsterdam, found ... the risk of developing the condition. The research ... yrs of age. All participants completed a questionnaire at the ...
... , SATURDAY, Sept. 24 (HealthDay News) -- Poor children ... to infection and disease -- than kids from higher-income ... the study findings revealed, some disadvantaged children grow up ... mother. Upward mobility also has been cited as ...
... Emerging Regions) Center at the University of Oklahoma is ... to focus on the life-sustaining resource, clean water. The ... to unsafe water, inadequate sanitation and poor hygiene than ... scarcity, but rather poverty, inequality and government failures. ...
... HealthDay Reporter , FRIDAY, Sept. 23 (HealthDay News) -- ... be vaccinated against human papillomavirus, a sexually transmitted disease that ... does not extend to boys and young men. At ... whether males also should be vaccinated for human papillomavirus, or ...
... disabilities increased in the U.S. among non-elderly adults during ... Mojtabai, MD, PhD, of the Johns Hopkins Bloomberg School ... found the prevalence of disability attributed to other chronic ... remained unchanged. The findings will appear in the November ...
... , THURSDAY, Sept. 22 (HealthDay News) -- Bed bug infestations ... than 100 Americans have become sickened from exposure to the ... across seven states, researchers said, and bed bug insecticide exposure ... of cases involved misuse," said report co-author Dr. Geoffrey Calvert, ...
Cached Medicine News:Health News:Good Moms Seem to Help Poor Kids Become Healthy Adults 2Health News:CDC Considers Vaccinating Boys, Not Just Girls, for HPV 2Health News:CDC Considers Vaccinating Boys, Not Just Girls, for HPV 3Health News:Bed Bug Insecticides Causing Sickness, Officials Warn 2Health News:Bed Bug Insecticides Causing Sickness, Officials Warn 3Health News:Bed Bug Insecticides Causing Sickness, Officials Warn 4
... the leading developer of laser diagnostics for ... Heidelberg Retina Tomograph 3 (HRT3), a newly-enhanced ... assessment, diagnosis and management of glaucoma. ,Like ... to produce a topographical image of a ...
The Escape Basket offers a side-by-side approach, unique to the market, for using a nitinol basket and holmium laser fiber together-providing physician control and independent manipulation of both th...
Simple, Effective Laparoscopic Irrigation Pumps from the Market Leader...
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
Medicine Products: